Autologous Fat Grafting & Regenerative Applications in Genital Aesthetics

The Biology of Adipose Tissue as a Regenerative Organ

• Adipose tissue composition — adipocytes, preadipocytes, endothelial progenitor cells, fibroblasts, pericytes and macrophages
• Stromal Vascular Fraction (SVF) — cellular composition, regenerative properties and the role of ADSCs (adipose-derived stem cells)
• ADSCs in the SVF: 2–10% of nucleated cells — paracrine signalling, angiogenesis and tissue regeneration mechanisms
• Adipose-derived regenerative cells (ADRCs) — clinical differentiation from mesenchymal stem cells and SVF
• Extracellular matrix remodelling, collagen synthesis stimulation and neovascularisation pathways in fat grafting

Evidence Base — Current Clinical Research (2024–2025)

• Systematic review evidence: ADSC and SVF-enriched fat grafts demonstrate graft survival rates of 60–80% at 3–6 months vs standard fat grafting (PMC, 2025)
• Microfat and Nanofat in GSM — VHI and FSD scores significantly improved at 18 months post-treatment (Aesthetic Surgery Journal, Oxford Academic)
• Combined AFG + PRP in genital ageing: FSFI total score increased by 9.0 ± 2.3 points; 92.1% patient satisfaction (Aesthetic Plast Surg, 2025)
• Autologous fat grafting for vulvar scar remodelling: improved contouring and quality-of-life outcomes (UCL / Royal Free NHS, 2025)
• Cell-supplemented fat transfer (CAL): current state, regulatory landscape and clinical translation evidence (University of Chicago, 2024)

Donor Site Selection & Anaesthesia

• Optimal donor sites — inner thigh, periumbilical abdomen and inner knee: cellular yield, ADSC concentration and technical considerations
• Tumescent anaesthesia — formulation, infiltration technique and epinephrine effect on adipocyte viability
• Office-based vs operating-room harvesting — technique adaptations, sterility standards and patient management

Harvesting Techniques — Cannula Selection & Pressure Control

• Harvesting cannula selection — diameter, tip design and negative-pressure optimisation for adipocyte viability
• Low-pressure aspiration technique — manual syringe vs mechanical pump: impact on cell survival and graft quality
• VASER-assisted liposuction (VASER UAL) — technique, emulsification and effect on adipocyte and ADSC viability
• Minimising traumatic harvest injury — evidence-based protocol for maximum viable cell yield
• Volume planning — harvesting volume calculation by indication and recipient site requirements

The Fat Processing Spectrum — From Macrofat to Nanofat

• Macrofat — definition, preparation by centrifugation/filtration and clinical applications: large-volume augmentation
• Millifat — intermediate particle-size preparation and indications: structural volumisation with improved survival
• Microfat — small-particle emulsification, cellular composition (adipocytes + ADSCs) and indications: labia majora, subcutaneous rejuvenation
• Nanofat — mechanical emulsification and filtration protocol, cell-rich stromal fraction and indications: intravaginal mucosal rejuvenation, atrophic vaginitis, GSM
• Comparative clinical applications — matching fat particle size to recipient tissue type, depth and therapeutic goal

SVF Isolation & Cell-Assisted Lipotransfer (CAL)

• SVF isolation protocol — enzymatic (collagenase) and mechanical methods: yield, purity and clinical-grade preparation
• Cell-Assisted Lipotransfer (CAL) — mixing SVF with conventional fat graft to enhance ADSC concentration and graft retention
• Centrifugation parameters — speed (g-force), duration and fractionation protocols by processing goal
• FDA and CE regulatory framework for SVF and ADSC clinical use — current international standards and compliance
• Puregraft® and closed-system processing — sterility, standardisation and clinical-grade fat preparation

PRP Integration — Autologous Bio-Filler Preparation

• PRP preparation — single and double spin centrifugation and platelet concentration optimisation
• Microfat + PRP combination — preparation protocol, mixing ratio and synergistic regenerative mechanism
• PRP as biological glue — fibrin matrix formation and graft stabilisation in the recipient site
• Clinical evidence for fat + PRP in genital aesthetics — AFG + PRP combination outcomes (FSFI, VLQ, 2025 data)

Injection Principles — Recipient Site Preparation & Cannula Technique

• Recipient site vascularisation — tissue plane selection and graft-to-host contact surface area optimisation
• Multi-planar injection technique — creating tissue planes with cannulas in different trajectories for uniform distribution
• Retrograde injection — small aliquot delivery per pass to maximise graft surface contact and minimise intravascular risk
• Cannula selection by fat type — diameter and tip design matched to Macrofat, Microfat and Nanofat delivery
• Injection volume planning — over-correction rationale, expected resorption rates by tissue type and secondary session planning

Labia Majora Augmentation — Lipofilling Protocol

• Anatomical assessment — labial volume-loss grading and treatment planning framework
• Microfat injection protocol for labia majora — entry point, tissue planes, distribution mapping and volume per session
• Stromal Enriched Lipograft™ technique — SVF-enriched fat grafting for labia majora: evidence and outcomes (Invivox / Aesthetic Plast Surg)
• Combining labial lipofilling with PRP, HA fillers and RF for comprehensive volumisation and rejuvenation
• Patient selection, realistic volume expectations and secondary touch-up session planning

Vulvovaginal Atrophy & GSM — Nanofat & Microfat Intravaginal Protocol

• Intravaginal Nanofat injection protocol — vaginal wall injection mapping, depth and volume per quadrant
• Clinical evidence: VHI significantly improved at 1 and 3 months; FSD normalised in 80% of patients at 6 months (Aesthetic Surgery Journal)
• Microfat for labia majora + Nanofat for vaginal walls — combined protocol for GSM with dual-site treatment
• Combining intravaginal fat grafting with laser/RF for synergistic mucosal collagen remodelling
• Session management, follow-up intervals and maintenance strategy for long-term GSM outcomes

Mons Pubis Contouring, Scar Remodelling & Reconstruction

• Mons pubis lipofilling — technique for volume restoration after significant weight loss or post-surgical contour deficiency
• Scar remodelling with fat grafting — mechanism, protocol and outcome evidence in genital scar management
• Post-surgical reconstruction with fat grafting — revision and corrective applications in genital aesthetics
• Fat grafting in FGM-related vulvar scar remodelling — UCL / Royal Free NHS evidence (Aesthetic Plast Surg, 2025)

Exosome Biology — Science, Evidence & Clinical Positioning

• Exosomes — definition, biogenesis and role as extracellular vesicles in intercellular communication and tissue repair
• Exosome cargo — mRNA, microRNA, proteins, lipids and growth factors: mechanisms of tissue regeneration and collagen stimulation
• MSC-derived exosomes vs adipose-derived exosomes — sourcing, preparation standards and clinical application comparison
• Current evidence base — systematic review and meta-analysis of exosome therapies in aesthetic medicine (Aesthetic Surgery Journal, February 2025)
• ISEV (International Society for Extracellular Vesicles) standards — minimum information requirements for clinical exosome studies
• Regulatory landscape — FDA and CE status, clinical trial requirements and responsible clinical use framework

Exosome Clinical Applications in Genital Aesthetics

• Vulvovaginal mucosal regeneration — exosome injection protocols for tissue renewal, hydration and collagen stimulation
• Scar and hyperpigmentation remodelling — MSC-exosome evidence for scar remodelling and pigmentation management (PROSPERO SR, 2025)
• Combining exosomes with Nanofat, PRP and laser/RF for amplified regenerative outcomes
• Exosome + RF microneedling combination — emerging clinical protocol and device-specific evidence
• Patient selection, sourcing criteria, quality benchmarks and informed consent for exosome procedures

Female Sexual Function — Regenerative Treatment Algorithms

• Pathophysiology of female sexual dysfunction (FSD) — vascular, hormonal, neurogenic and connective tissue mechanisms
• FSFI (Female Sexual Function Index) and VLQ (Vaginal Laxity Questionnaire) — clinical outcome measurement frameworks
• Fat grafting + PRP for FSD: FSFI total score increased by 9.0 ± 2.3 points across 6 FSFI dimensions (2025 clinical data)
• G-Spot augmentation with Microfat and PRP — technique, evidence and outcome expectations
• Perineal body fat grafting — structural support, sensation improvement and dyspareunia management

GSM — Combination Regenerative Protocol

• GSM multi-modal protocol: Nanofat intravaginal + PRP + laser/RF + local hormone therapy — evidence-based integration
• Lactobacillus restoration and vaginal microbiome — the regenerative mechanism linking fat grafting to vaginal health restoration
• Fluid transudation and natural lubrication restoration — clinical outcomes in GSM patients at 12–18 months
• Combining fat grafting with O-Shot® for synergistic sexual wellness outcomes

Safety Protocols & Complication Prevention

• Intravascular fat injection risk — prevention strategies, retrograde technique and small-aliquot injection discipline
• Fat necrosis and cyst formation — recognition, incidence, prevention and management protocols
• Infection risk in fat grafting — sterility standards, antibiotic prophylaxis and post-procedural surveillance
• Graft resorption — rates by technique, patient factors and secondary session planning framework
• Informed consent framework specific to autologous fat grafting, SVF and exosome procedures

Patient Selection, Outcome Measurement & Follow-Up

• Evidence-based patient selection criteria — BMI, donor fat availability, indication and treatment goals
• Pre-procedural photography, volume documentation and baseline outcome benchmarking
• Post-procedural care — compression, activity restriction and healing optimisation protocols
• Follow-up intervals — 1, 3, 6 and 12-month assessment frameworks for fat grafting outcomes
• Managing patient expectations — realistic communication of volume retention, graft survival and secondary session likelihood

Combination Regenerative Protocol Design

• Fat grafting + PRP + exosomes: the 2025 combination regenerative protocol endorsed by leading academic centres
• Fat grafting + laser/RF: synergistic volumisation and collagen remodelling — sequencing and interval planning
• Fat grafting + mesotherapy: combining cellular regeneration with biostimulation for enhanced vulvovaginal rejuvenation
• Building a regenerative gynaecology practice — procedure sequencing, patient journey design and treatment planning frameworks

Live Interactive Case Presentation & Faculty Q&A

• Real patient cases — before-and-after clinical analysis with faculty commentary on technique, volume and protocol design
• Challenging case discussion — thin patients, prior scarring, GSM management and post-surgical correction
• Open Q&A session — ask faculty your clinical, technical and regulatory questions directly in real time
• Troubleshooting sub-optimal outcomes — under-correction, asymmetry and secondary procedure planning